Impairment LossEL - Pharmaceuticals Reportable Segments Member、Liabilities、Effect Resulting From Change Of Accounting Period Of Consolidated SubsidiariesRE他1件

【期間】

年度	Impairment LossEL - Pharmaceuticals Reportable Segments Member		Liabilities		Effect Resulting From Change Of Accounting Period Of Consolidated SubsidiariesRE		投資有価証券評価損
2013/12	-		-		-		985百万

2013年12月

Impairment LossEL - Pharmaceuticals Reportable Segments Member: -
Liabilities: -
Effect Resulting From Change Of Accounting Period Of Consolidated SubsidiariesRE: -
投資有価証券評価損: 9億8500万